To investigate the ability of prokaryotic microorganisms to activate strategies in adapting themselves to the environmental stress induced by exposure to extremely low frequency electromagnetic fields (ELF-EMF), cultures of Escherichia coli ATCC 700926 exposed at 50 Hz EMF (0.1, 0.5, 1.0 mT), and the respective sham-exposed controls were studied for: the total and culturable counts, the viability status, the antimicrobial susceptibility pattern, the morphological analysis, the genotypical and transcriptional profile. Exposed samples and controls displayed similar total and culturable counts, whereas an increased cell viability was observed in exposed samples re-incubated for 24 h outside of the solenoid compared to the corresponding controls. An exposure to 50 Hz EMF of 20-120 min produced a significant change of E. coli morphotype with a presence of coccoid cells also aggregated in clusters after re-incubation of 24 h outside of the solenoid. Atypical lengthened bacterial forms were also observed suggesting a probable alteration during cell division. No changes among DNA fingerprintings and some differences in RNA-AFLP analysis were observed for each 50 Hz EMF intensities evaluated. Our results indicate that an exposure to 50 Hz EMF acts as a stressing factor on bacteria which can represent a suitable model to investigate acute and chronic effects related to ELF-EMF exposure.

The aim of this work was to evaluate the antibacterial effect of plant extracts as alternative and[sol ]or as active agents supporting antibiotics for treating Helicobacter pylori infection. The effect of either, ethanolic or aqueous extracts from 17 plant materials were studied against one H. pylori standard strain and 11 clinical isolates using a disc diffusion test and by evaluating the minimum inhibitory concentration (MIC) on solid media. An inhibitory activity against H. pylori strains was recorded in a large percentage of tested plants. MIC values of ethanolic extracts were from two to four concentration steps lower than the aqueous ones. In particular, ethanolic extracts of Cuminum cyminum L. and Propolis expressed MIC90 values of 0.075 mg/mL. The results show a significant in vitro effect of plant extracts against H. pylori that could be considered a valuable support in the treatment of the infection and may contribute to the development of new and safe agents for inclusion in anti-H. pylori regimens.

This study evaluates the airborne microflora in research laboratories of the University of Chieti (Italy). A quali-quantitative evaluation of the index microbial air contamination was performed using the settle plate method. The microbial air contamination was evaluated during 6 months in three university buildings (A, B, and C). Nutrient agar plates were exposed, monthly, for 1 h at the morning and the afternoon to evaluate the colony forming units per plate per hour. Together with the quantitative analysis, the most frequent bacterial and fungal colonies isolated were also characterized. Moreover, in each sampling, the number of the occupants in each room was recorded to evaluate a possible relationship with the microbial pollution. The microbial concentration was always within the limit values defined for these environments. Buildings A and C displayed a seasonal fluctuation of airborne microflora with the increase in microbial concentration in the warmer season (April to June) in respect to the colder period (October to December). The most common microorganisms detected in the indoor air of the examined buildings were Gram-positive bacteria, belonged to the genera Staphylococcus, Bacillus, and Actinomyces. Data presented here underline the useful monitoring of the research university laboratories also emphasizing the effectiveness of the settle plate method.

Propolis and Zingiber officinale have been shown to be specifically targeted against Helicobacter pylori strains, to possess antiinflammatory, antioxidant and antitumoral activity and to be used in traditional medicine for the treatment of gastrointestinal ailments. Considering that these natural products could potentially serve as novel therapeutic tools also in combination with an antibiotic, the aim of this work was to evaluate their effect when combined with clarithromycin on clinical H. pylori isolates (n = 25), characterized in respect to both clarithromycin susceptibility and the presence of the cagA gene. The results showed that the combinations of propolis extract + clarithromycin and Z. officinale extract + clarithromycin exhibited improved inhibition of H. pylori with synergistic or additive activity. Interestingly, the susceptibility to combinations was significantly independent of the microbial clarithromycin susceptibility status. Only one H. pylori strain showed antagonism towards the Z. officinale extract + clarithromycin combination. The data demonstrate that combinations of propolis extract + clarithromycin and Z. officinale extract + clarithromycin have the potential to help control H. pylori-associated gastroduodenal disease.

SummaryThe viscoelastic properties of mono‐microbial biofilms produced by ocular and reference staphylococcal strains were investigated. The microorganisms were characterized for their haemolytic activity and agr typing and the biofilms, grown on stainless steel surface under static conditions, were analysed by Confocal Laser Scanning Microscopy. Static and dynamic rheometric tests were carried out to determine the steady‐flow viscosity and the elastic and viscous moduli. The analysed biofilms showed the typical time‐dependent behaviour of viscoelastic materials with considerable elasticity and mechanical stability except for Staphylococcus aureus ATCC 29213 biofilm which showed a very fragile structure. In particular, S. aureus 6ME biofilm was more compact than other staphylococcal biofilms studied with a yield stress ranging between 2 and 3 Pa. The data obtained in this work could represent a starting point for developing new therapeutic strategies against biofilm‐associated infections, such as improving the drug effect by associating an antimicrobial agent with a biofilm viscoelasticity modifier.